Several large-scale electronic health records studies have reported increased diagnostic
rates for neuropsychiatric disorders following Coronavirus disease 2019 [COVID-19 or …

Over 65 million people suffer from recurrent, unprovoked seizures. The lack of validated
biomarkers specific for myriad forms of epilepsy makes diagnosis challenging. Diagnosis …

Omicron generally causes milder disease than previous strains of severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), especially in fully vaccinated individuals. However …

We read with interest the recent meta-analysis assessing the clinical efficacy and safety of
nirmatrelvir plus ritonavir (NMV-r) in the treatment of patients with COVID-19. 1 Based on the …

In 2017, one of us reviewed advances in epilepsy (Manford in J Neurol 264: 1811–1824,
2017). The current paper brings that review up to date and gives a slight change in …

Introduction Migraine pharmacological therapies targeting calcitonin gene-related peptide
(CGRP), including monoclonal antibodies and gepants, have shown clinical effect and …

Introduction SARS-CoV-2 infection can affect any organ, including both the central nervous
system (CNS) and peripheral nervous system (PNS). The aim of this study was to explore …

Background and Objective Following the outbreak of viral infections from the severe acute
respiratory syndrome coronavirus 2 virus in 2019 (coronavirus disease 2019 [COVID-19]) …

The intricate relationship between viruses and epilepsy involves a bidirectional interaction.
Certain viruses can induce epilepsy by infecting the brain, leading to inflammation, damage …

Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis: A
Retrospective Cohort Study Taquet M, Devinsky O, Cross JH, Harrison PJ, Sen A …